Skip to Content
Merck
  • Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation.

Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation.

Life sciences (1987-09-07)
P M Plotsky, S Otto, S Sutton
ABSTRACT

Secretion of corticotropin releasing factor (CRF) from the hypothalamic paraventricular nuclei into the hypophysial-portal circulation is modulated by a variety of neuronal afferents. Effects of intracerebroventricular acetylcholine (ACH), gamma-aminobutyric acid (GABA) and epinephrine (EPI) on immunoreactive (ir) CRF concentration in portal plasma were directly evaluated in urethanized male rats. ACH (0.1-10 nmole) administration was associated with a dose-dependent elevation of portal irCRF which was attenuated by pretreatment with either muscarinic or nicotinic receptor antagonists. GABA (0.1-10 nmole) also caused inhibition of irCRF concentration in the portal plasma which was prevented by bicuculline pretreatment. Finally, EPI (0.1-10 nmole) facilitated irCRF secretion via alpha 1- and beta-adrenergic mechanisms. These observations provide the first direct information on possible neurotransmitter actions on hypothalamic CRF secretion.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,2,2,6,6-Pentamethylpiperidine, 97%